Related Experiment Video
Updated: Sep 11, 2025

14:32
Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care
Published on: February 16, 2011
23.8K
The Intersection of Disability and Cancer: Improving Outcomes in Cancer Patients With Disabilities
Jiali Cai1, Yingjoy Li2, Oliver S Eng1
1Irvine-Department of Surgery, University of California, Orange, CA.
Annals of Surgery
|August 12, 2025
Summary
Patients with cancer and disabilities experience significant healthcare access barriers and poorer health outcomes. Addressing these disparities is crucial for improving care for this vulnerable population.
Area of Science:
- Oncology
- Health Services Research
- Disability Studies
Background:
- Individuals with disabilities encounter unique healthcare navigation challenges, including structural and socioeconomic barriers.
- These challenges can potentially delay cancer diagnosis and treatment, yet remain under-researched.
Purpose of the Study:
- To investigate the barriers to timely healthcare access for cancer patients with disabilities.
- To evaluate the impact of these barriers on health-related outcomes in cancer patients with disabilities.
Main Methods:
- Utilized data from the All of Us Research Program, identifying patients with breast, lung, colorectal, melanoma, pancreatic, and esophageal cancers.
- Stratified patients by disability status (mobility, hearing, vision, communication, cognition) and employed propensity score matching for group balance.
- Assessed outcomes including healthcare access, financial burden, and physical and emotional health.
Main Results:
- Nearly 25% of cancer patients in the study reported a disability, often associated with older age, minority status, lower income, and unemployment.
- Patients with disabilities faced significantly higher out-of-pocket costs, transportation issues, and difficulties accessing medications, mental health services, specialty care, and follow-up care.
- Disability was linked to worse physical and mental health, increased pain, and reduced quality of life.
Conclusions:
- Significant disparities exist in timely and affordable healthcare access for individuals with cancer and disabilities.
- These access barriers contribute to adverse health outcomes, highlighting the need for targeted interventions.
- Further research is essential to understand and mitigate these inequities for vulnerable cancer patient populations.
Related Concept Videos
Cancer Survival Analysis
455
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
455
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660

